drugset / Trial / NCT07474545
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KL0011034 Injection in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single intravenous doses of KL0011034 injection in healthy volunteers.
Timeline
- Start
- 2026-03-02
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Etomidate | Small molecule | — | Intravenous |
| Subject | KL0011034 | Unknown | — | Intravenous |
Indications
No indication recorded.